SEC Form 4 · accession 0001209191-16-099427
Adverum Biotechnologies, Inc. · ADVM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark S. Blumenkranz
Director
Period of report
Feb 12, 2016
Accepted (ET)
Feb 17, 2016 · 5:37 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001501756
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 12, 2016 | A | 8,333 | $0.00 | A | 531,322 | D | |
| Common StockF2 | holding | — | — | — | 10,531 | I | See Footnote | |
| Common StockF3 | holding | — | — | — | 10,531 | I | See Footnote | |
| Common StockF4 | holding | — | — | — | 10,531 | I | See Footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $4.80 | Feb 12, 2016 | A | 11,905 | A | Feb 12, 2017 | Feb 11, 2026 | Common Stock | 11,905 | 11,905 | D |
Explanation of responses
- F1Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of Common Stock of the Issuer for each one (1) RSU upon the vesting thereof. Such RSUs vest with respect to 100% of the shares subject thereto on February 12, 2017.
- F2The shares are held directly by the Carla Helene Blumenkranz Irrevocable Trust.
- F3The shares are held directly by the Erik Davis Blumenkranz Irrevocable Trust.
- F4The shares are held directly by the Scott Aubrey Blumenkranz Irrevocable Trust.